Replimune Group, Inc. (REPL)
Healthcare · Biotechnology · NASDAQ
Replimune Group, Inc. (REPL) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.01B.
| Market cap | $1.01B |
|---|
| Trailing P/E | — |
|---|
| FCF yield | — |
|---|
| Revenue growth (YoY) | — |
|---|
| EPS growth (YoY) | — |
|---|
| FCF/share growth (YoY) | — |
|---|
| Exchange | NASDAQ |
|---|
| Sector | Healthcare |
|---|
| Industry | Biotechnology |
|---|
See more: Healthcare stocks →